Should We Invest Behind Moderna’s ($MRNA) Covid-19 Vaccine?

The race for a Covid-19 vaccine has spurred a more than 300 percent increase in Moderna's share price. But with multiple companies pursuing vaccines, how valuable can Moderna possibly be?
Share on facebook
Share on twitter
Share on linkedin
Share on email
(By Sonis Photography)
(By Sonis Photography)

The race for a Covid-19 vaccine has spurred a more than 300 percent increase in Moderna's share price. But with multiple companies pursuing vaccines, how valuable can Moderna possibly be?

Must be a member to see this page, sign up here! https://acouplecents.com/signup/roic/

  • I bought into a small position in early Feb ($23.50/share) and I’m still riding it out since they were the first vaccine to get into phase 3 testing. There are definitive red flags, but for me, it’s worth the risk to see how phase 3 pans out. Beyond the coronavirus vaccine, having the first approved mRNA vaccine could open doors for future mRNA vaccines. Just my two cents. What do you guys think?

  • Good points. Also saw the CMO and CTO selling all their shares. I’m less concerned about the CTO but if the CMO (Chief Medical Officer) sold ALL their shares….that is definitely not a good feeling for investors. MRNA is a equity you can’t even buy right now (or short). Watching from the sidelines here.

  • Subscribe to our daily newsletter!

    Trending Now

    Latest Videos

    Related Posts

    >